Analyzing The Latest Anti-Pdgf Trial Results

Analyzing the latest anti-PDGF trial results

Ophthalmology Times

Results of a Phase IIa trial investigating rozanolixizumab for CIDP

MILESTONE trial results: MRD response-adapted deferral of autoSCT in newly diagnosed myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

YOSEMITE/RHINE trial: faricimab vs aflibercept in patients with DME: Andreas Pollreisz, ARVO 2023

Touch Medical Media

Gene Therapy and Pompe Disease: Preliminary Results From Phase I/II Study With AT845

Pravin U Dugel: Intravitreal OPT-302 Study Results

Meta-analysis of the latest anti-amyloid immunotherapies: benefit vs risk

Gene Therapy for Wet AMD Reduces Need for Ant-VEGF Injections | ASRS

Managed Healthcare Executive

PDGF wound closure

Michelle Dawson

The impact of MRD standardized assessment by FDG-PET/CT in patients enrolled in the FORTE trial

VJHemOnc – Video Journal of Hematology & HemOnc

Mechanisms of Angiogenesis Inhibitors in Metastatic Colorectal Cancer

"Macular Degeneration: Innovations and Insights" by Dr. Steven Bailey and Dr. Christina Flaxel

OHSU

New fast track vaccine just approved by the FDA, will you get it?

Dr. Andrea O'Connor

Benefit and risk analysis from the phase III OPTiM trial

Latent Class Analysis Identifies 2 Clinical Phenotypes of Immune Checkpoint Inhibitor-Induced

Johns Hopkins Medicine

Macular Degeneration: The View Ahead in Research and Treatment

OHSU

Targeting the Insulin-like Growth Factor Binding Proteins: A New Treatment Strategy For Castratio...

UBC Urology Rounds

Phase II trial of AG-946 in patients with low-risk MDS and anemia

VJHemOnc – Video Journal of Hematology & HemOnc

Results of pridopidine use in the Phase II HEALEY-ALS platform trial

Faricimab vs aflibercept in patients with DME: Jennifer Lim, ARVO 2023

Touch Medical Media